vs
Indivior Pharmaceuticals, Inc.（INDV）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
Indivior Pharmaceuticals, Inc.的季度营收约是BRC Group Holdings, Inc.的1.9倍（$357.0M vs $188.3M），BRC Group Holdings, Inc.净利率更高（47.9% vs 28.9%，领先19.1%）
Indivior是一家全球专科制药企业，专注于开发和商业化针对阿片类物质使用障碍、酒精依赖及相关精神健康疾病的循证治疗方案，核心市场覆盖北美与欧洲，旗下多款获批疗法服务于医疗需求未被充分满足的患者群体。
INDV vs RILY — 直观对比
营收规模更大
INDV
是对方的1.9倍
$188.3M
净利率更高
RILY
高出19.1%
28.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $357.0M | $188.3M |
| 净利润 | $103.0M | $90.3M |
| 毛利率 | 82.1% | 79.5% |
| 营业利润率 | 22.7% | 32.3% |
| 净利率 | 28.9% | 47.9% |
| 营收同比 | — | -21.9% |
| 净利润同比 | 390.5% | 1710.8% |
| 每股收益（稀释后） | $0.79 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INDVRILY
| Q4 25 | $357.0M | $188.3M | ||
| Q3 25 | $314.0M | $215.3M | ||
| Q2 25 | $302.0M | $188.2M | ||
| Q1 25 | $266.0M | $197.2M | ||
| Q4 24 | — | $241.0M | ||
| Q3 24 | $307.0M | $225.5M | ||
| Q2 24 | $299.0M | $256.0M | ||
| Q1 24 | — | $263.4M |
净利润INDVRILY
| Q4 25 | $103.0M | $90.3M | ||
| Q3 25 | $42.0M | $91.1M | ||
| Q2 25 | $18.0M | $139.5M | ||
| Q1 25 | $47.0M | $-10.0M | ||
| Q4 24 | — | $-5.6M | ||
| Q3 24 | $22.0M | $-284.4M | ||
| Q2 24 | $-97.0M | $-433.6M | ||
| Q1 24 | — | $-49.2M |
毛利率INDVRILY
| Q4 25 | 82.1% | 79.5% | ||
| Q3 25 | 73.2% | 83.7% | ||
| Q2 25 | 82.8% | 81.3% | ||
| Q1 25 | 83.1% | 81.4% | ||
| Q4 24 | — | 79.8% | ||
| Q3 24 | 78.5% | 82.1% | ||
| Q2 24 | 73.6% | 84.5% | ||
| Q1 24 | — | 85.3% |
营业利润率INDVRILY
| Q4 25 | 22.7% | 32.3% | ||
| Q3 25 | 13.7% | 30.4% | ||
| Q2 25 | 23.8% | 5.7% | ||
| Q1 25 | 24.8% | -31.2% | ||
| Q4 24 | — | -69.2% | ||
| Q3 24 | 11.4% | -36.4% | ||
| Q2 24 | -39.5% | -90.8% | ||
| Q1 24 | — | -6.1% |
净利率INDVRILY
| Q4 25 | 28.9% | 47.9% | ||
| Q3 25 | 13.4% | 42.3% | ||
| Q2 25 | 6.0% | 74.1% | ||
| Q1 25 | 17.7% | -5.1% | ||
| Q4 24 | — | -2.3% | ||
| Q3 24 | 7.2% | -126.1% | ||
| Q2 24 | -32.4% | -169.4% | ||
| Q1 24 | — | -18.7% |
每股收益（稀释后）INDVRILY
| Q4 25 | $0.79 | $2.78 | ||
| Q3 25 | $0.33 | $2.91 | ||
| Q2 25 | $0.14 | $4.50 | ||
| Q1 25 | $0.38 | $-0.39 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $0.16 | $-9.39 | ||
| Q2 24 | $-0.72 | $-14.35 | ||
| Q1 24 | — | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $195.0M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $-98.0M | $-171.5M |
| 总资产 | $1.2B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资INDVRILY
| Q4 25 | $195.0M | $226.6M | ||
| Q3 25 | $445.0M | $184.2M | ||
| Q2 25 | $510.0M | $267.4M | ||
| Q1 25 | $373.0M | $138.3M | ||
| Q4 24 | — | $146.9M | ||
| Q3 24 | — | $159.2M | ||
| Q2 24 | — | $236.9M | ||
| Q1 24 | — | $190.7M |
总债务INDVRILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益INDVRILY
| Q4 25 | $-98.0M | $-171.5M | ||
| Q3 25 | $-207.0M | $-260.5M | ||
| Q2 25 | $-257.0M | $-351.7M | ||
| Q1 25 | $-285.0M | $-496.8M | ||
| Q4 24 | — | $-488.2M | ||
| Q3 24 | $-310.0M | $-497.6M | ||
| Q2 24 | $-281.0M | $-218.3M | ||
| Q1 24 | — | $228.4M |
总资产INDVRILY
| Q4 25 | $1.2B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.5B | $1.5B | ||
| Q1 25 | $1.4B | $1.5B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $3.2B | ||
| Q1 24 | — | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-221.0M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $-245.0M | — |
| 自由现金流率自由现金流/营收 | -68.6% | — |
| 资本支出强度资本支出/营收 | 6.7% | — |
| 现金转化率经营现金流/净利润 | -2.15× | 0.29× |
| 过去12个月自由现金流最近4个季度 | $-93.0M | — |
8季度趋势，按日历期对齐
经营现金流INDVRILY
| Q4 25 | $-221.0M | $26.2M | ||
| Q3 25 | $-39.0M | $-60.6M | ||
| Q2 25 | $158.0M | $-25.6M | ||
| Q1 25 | $75.0M | $184.0K | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | $2.0M | $19.5M | ||
| Q2 24 | $88.0M | $111.5M | ||
| Q1 24 | — | $135.4M |
自由现金流INDVRILY
| Q4 25 | $-245.0M | — | ||
| Q3 25 | $-59.0M | — | ||
| Q2 25 | $141.0M | — | ||
| Q1 25 | $70.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-5.0M | — | ||
| Q2 24 | $84.0M | — | ||
| Q1 24 | — | — |
自由现金流率INDVRILY
| Q4 25 | -68.6% | — | ||
| Q3 25 | -18.8% | — | ||
| Q2 25 | 46.7% | — | ||
| Q1 25 | 26.3% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -1.6% | — | ||
| Q2 24 | 28.1% | — | ||
| Q1 24 | — | — |
资本支出强度INDVRILY
| Q4 25 | 6.7% | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 1.3% | — | ||
| Q1 24 | — | — |
现金转化率INDVRILY
| Q4 25 | -2.15× | 0.29× | ||
| Q3 25 | -0.93× | -0.66× | ||
| Q2 25 | 8.78× | -0.18× | ||
| Q1 25 | 1.60× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INDV
| Sublocade | $233.0M | 65% |
| Sublingual And Other | $69.0M | 19% |
| Other | $49.0M | 14% |
| Perseris | $6.0M | 2% |
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
